Epigenetic Regulation by Sulforaphane: Opportunities for Breast and Prostate Cancer Chemoprevention

Lauren L. Atwell, Laura M. Beaver, Jackilen (Jackie) Shannon, David E. Williams, Roderick H. Dashwood, Emily Ho

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Sulforaphane (SFN) is a phytochemical derived from cruciferous vegetables that has multiple molecular targets and anti-cancer properties. Researchers have demonstrated several chemopreventive benefits of SFN consumption, such as reductions in tumor growth, increases in cancer cell apoptosis, and disruption of signaling within tumor microenvironments both in vitro and in vivo. Emerging evidence indicates that SFN exerts several of its chemopreventive effects by altering epigenetic mechanisms. This review summarizes evidence of the impact of SFN on epigenetic events and how they relate to the chemopreventive effects of SFN observed in preclinical and clinical studies of breast and prostate cancers. Specific areas of focus include the role of SFN in the regulation of cell cycle, apoptosis, inflammation, antioxidant defense, and cancer cell signaling and their relationships to epigenetic mechanisms. Finally, remaining challenges and research needs for translating mechanistic work with SFN into human studies and clinical intervention trials are discussed.

Original languageEnglish (US)
Pages (from-to)102-111
Number of pages10
JournalCurrent Pharmacology Reports
Volume1
Issue number2
DOIs
StatePublished - Apr 1 2015

Fingerprint

Chemoprevention
Epigenomics
Prostatic Neoplasms
Breast Neoplasms
Tumors
Neoplasms
Cells
Apoptosis
Cell signaling
Tumor Microenvironment
Vegetables
Phytochemicals
sulforafan
Cell Cycle
Antioxidants
Research Personnel
Clinical Trials
Inflammation
Growth
Research

Keywords

  • Breast
  • Cancer
  • Chemoprevention
  • Epigenetics
  • Prostate
  • Sulforaphane

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Biochemistry
  • Genetics

Cite this

Atwell, L. L., Beaver, L. M., Shannon, J. J., Williams, D. E., Dashwood, R. H., & Ho, E. (2015). Epigenetic Regulation by Sulforaphane: Opportunities for Breast and Prostate Cancer Chemoprevention. Current Pharmacology Reports, 1(2), 102-111. https://doi.org/10.1007/s40495-014-0002-x

Epigenetic Regulation by Sulforaphane : Opportunities for Breast and Prostate Cancer Chemoprevention. / Atwell, Lauren L.; Beaver, Laura M.; Shannon, Jackilen (Jackie); Williams, David E.; Dashwood, Roderick H.; Ho, Emily.

In: Current Pharmacology Reports, Vol. 1, No. 2, 01.04.2015, p. 102-111.

Research output: Contribution to journalReview article

Atwell, LL, Beaver, LM, Shannon, JJ, Williams, DE, Dashwood, RH & Ho, E 2015, 'Epigenetic Regulation by Sulforaphane: Opportunities for Breast and Prostate Cancer Chemoprevention', Current Pharmacology Reports, vol. 1, no. 2, pp. 102-111. https://doi.org/10.1007/s40495-014-0002-x
Atwell, Lauren L. ; Beaver, Laura M. ; Shannon, Jackilen (Jackie) ; Williams, David E. ; Dashwood, Roderick H. ; Ho, Emily. / Epigenetic Regulation by Sulforaphane : Opportunities for Breast and Prostate Cancer Chemoprevention. In: Current Pharmacology Reports. 2015 ; Vol. 1, No. 2. pp. 102-111.
@article{aa38c091a04e4660b745523f38648690,
title = "Epigenetic Regulation by Sulforaphane: Opportunities for Breast and Prostate Cancer Chemoprevention",
abstract = "Sulforaphane (SFN) is a phytochemical derived from cruciferous vegetables that has multiple molecular targets and anti-cancer properties. Researchers have demonstrated several chemopreventive benefits of SFN consumption, such as reductions in tumor growth, increases in cancer cell apoptosis, and disruption of signaling within tumor microenvironments both in vitro and in vivo. Emerging evidence indicates that SFN exerts several of its chemopreventive effects by altering epigenetic mechanisms. This review summarizes evidence of the impact of SFN on epigenetic events and how they relate to the chemopreventive effects of SFN observed in preclinical and clinical studies of breast and prostate cancers. Specific areas of focus include the role of SFN in the regulation of cell cycle, apoptosis, inflammation, antioxidant defense, and cancer cell signaling and their relationships to epigenetic mechanisms. Finally, remaining challenges and research needs for translating mechanistic work with SFN into human studies and clinical intervention trials are discussed.",
keywords = "Breast, Cancer, Chemoprevention, Epigenetics, Prostate, Sulforaphane",
author = "Atwell, {Lauren L.} and Beaver, {Laura M.} and Shannon, {Jackilen (Jackie)} and Williams, {David E.} and Dashwood, {Roderick H.} and Emily Ho",
year = "2015",
month = "4",
day = "1",
doi = "10.1007/s40495-014-0002-x",
language = "English (US)",
volume = "1",
pages = "102--111",
journal = "Current Pharmacology Reports",
issn = "2198-641X",
publisher = "Springer International Publishing AG",
number = "2",

}

TY - JOUR

T1 - Epigenetic Regulation by Sulforaphane

T2 - Opportunities for Breast and Prostate Cancer Chemoprevention

AU - Atwell, Lauren L.

AU - Beaver, Laura M.

AU - Shannon, Jackilen (Jackie)

AU - Williams, David E.

AU - Dashwood, Roderick H.

AU - Ho, Emily

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Sulforaphane (SFN) is a phytochemical derived from cruciferous vegetables that has multiple molecular targets and anti-cancer properties. Researchers have demonstrated several chemopreventive benefits of SFN consumption, such as reductions in tumor growth, increases in cancer cell apoptosis, and disruption of signaling within tumor microenvironments both in vitro and in vivo. Emerging evidence indicates that SFN exerts several of its chemopreventive effects by altering epigenetic mechanisms. This review summarizes evidence of the impact of SFN on epigenetic events and how they relate to the chemopreventive effects of SFN observed in preclinical and clinical studies of breast and prostate cancers. Specific areas of focus include the role of SFN in the regulation of cell cycle, apoptosis, inflammation, antioxidant defense, and cancer cell signaling and their relationships to epigenetic mechanisms. Finally, remaining challenges and research needs for translating mechanistic work with SFN into human studies and clinical intervention trials are discussed.

AB - Sulforaphane (SFN) is a phytochemical derived from cruciferous vegetables that has multiple molecular targets and anti-cancer properties. Researchers have demonstrated several chemopreventive benefits of SFN consumption, such as reductions in tumor growth, increases in cancer cell apoptosis, and disruption of signaling within tumor microenvironments both in vitro and in vivo. Emerging evidence indicates that SFN exerts several of its chemopreventive effects by altering epigenetic mechanisms. This review summarizes evidence of the impact of SFN on epigenetic events and how they relate to the chemopreventive effects of SFN observed in preclinical and clinical studies of breast and prostate cancers. Specific areas of focus include the role of SFN in the regulation of cell cycle, apoptosis, inflammation, antioxidant defense, and cancer cell signaling and their relationships to epigenetic mechanisms. Finally, remaining challenges and research needs for translating mechanistic work with SFN into human studies and clinical intervention trials are discussed.

KW - Breast

KW - Cancer

KW - Chemoprevention

KW - Epigenetics

KW - Prostate

KW - Sulforaphane

UR - http://www.scopus.com/inward/record.url?scp=85016877884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016877884&partnerID=8YFLogxK

U2 - 10.1007/s40495-014-0002-x

DO - 10.1007/s40495-014-0002-x

M3 - Review article

AN - SCOPUS:85016877884

VL - 1

SP - 102

EP - 111

JO - Current Pharmacology Reports

JF - Current Pharmacology Reports

SN - 2198-641X

IS - 2

ER -